- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
The Future of US Antimicrobial Resistance is in Our Hands and There is Work to Do
Steer clear of antibiotic Rxs whenever possible, says Anne Meneghetti, MD, to help the US get back to pre-COVID levels of antimicrobial stewardship.
Is it flu? Is it COVID? Is it allergies? Test first, recommends Anne Meneghetti, MD, and then carefully consider options for the next steps.
The COVID-19 pandemic led to lost ground against antimicrobial resistance in the US, says Meneghetti, who trained as a pulmonary critical care physician and is now executive director of medical information at point-of-care mobile reference app epocrates. She adds that the 2022-23 respiratory virus season is going to look different all over the country based on local vaccination status, mask wearing, and other public and individual variables. One of the most important decisions prescribers will make this season is when and when not to write for an antibiotic.
Meneghetti shared her thoughts with Patient Care© about returning to pre-pandemic levels of antimicrobial stewardship in the US; an excerpt of the conversation follows in the video below.
